Inherited bleeding disorders in older women

Maturitas

Volumn 72, Issue 1, 2012, Pages 35-41

  Kadir, Rezan A ^a   Sharief, Lava A ^a   Lee, Christine A ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Inherited bleeding disorders (IBDs); Menopause; Menorrhagia; Von Willebrand disease (VWD)

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; PROTHROMBIN; VON WILLEBRAND FACTOR;

ABDOMINAL PAIN; AGE; BLEEDING; BLEEDING DISORDER; BLOOD CLOTTING FACTOR 11 DEFICIENCY; DYSMENORRHEA; ENDOMETRIOSIS; ENDOMETRIUM ABLATION; ENDOMETRIUM POLYP; EPISTAXIS; FAMILY HISTORY; FEMALE; GYNECOLOGIC DISEASE; GYNECOLOGIC SURGERY; HALF LIFE TIME; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HORMONE SUBSTITUTION; HUMAN; INHERITED BLEEDING DISORDER; LABORATORY TEST; MENORRHAGIA; MENSTRUATION; OVARY CYST; PARTIAL THROMBOPLASTIN TIME; POSTMENOPAUSE; POSTPARTUM HEMORRHAGE; PROTHROMBIN TIME; QUALITY OF LIFE; REVIEW; SKIN BRUISING; THROMBOCYTE DISORDER; UTERINE CERVIX CANCER; UTERUS CANCER; UTERUS MYOMA; VON WILLEBRAND DISEASE;

BLOOD COAGULATION DISORDERS, INHERITED; BLOOD PLATELET DISORDERS; FEMALE; HEMORRHAGIC DISORDERS; HUMANS; MENORRHAGIA; RARE DISEASES; VON WILLEBRAND DISEASES;

EID: 84862825544     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2012.02.008     Document Type: Review

References (53)

1. Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004;111(July (7)):734-40.
2. Kouides PA, Byams VR, Philipp CS, Stein SF, Heit JA, Lukes AS, et al. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid. Br J Haematol 2009;145(April (2)):212-20.
3. Tsai H-M. Shear stress and von Willebrand factor in health and disease. Semin Thromb Hemost 2003;29(October (5)):479-88.
4. Hoffman M, Monroe 3rd DM. A cell-based model of hemostasis. Thromb Haemost 2001;85(June (6)):958-65.
5. Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010;8(September (9)):2063-5.
6. Rizza CR, Rhymes IL, Austen DE, Kernoff PB, Aroni SA. Detection of carriers of haemophilia: a "blind" study. Br J Haematol 1975;30(August (4)):447-56.
7. White 2nd GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2001;85(March (3)):560.
8. Seligsohn U. High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews. Blood 1978;51(June (6)):1223-8.
9. Bolton-Maggs PH, Young Wan-Yin B, McCraw AH, Slack J, Kernoff PB. Inheritance and bleeding in factor XI deficiency. Br J Haematol 1988;69(August (4)):521-8.
10. Bolton-Maggs PH. Factor XI deficiency and its management. Haemophilia 2000;6(July (Suppl. 1)):100-9.
11. Peyvandi F, Palla R, Menegatti M, Mannucci PM. Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management. Semin Thromb Hemost 2009;35(June (4)):349-55.
12. Von Willebrand EA. Hereditary pseudohaemophilia. Haemophilia 1999;5(May (3)):223-31 [discussion 222].
13. Sadler JE, Budde U, Eikenboom JCJ, Favaloro EJ, Hill FGH, Holmberg L, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand factor. J Thromb Haemost 2006;4(October (10)):2103-14.
14. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 1999;82(November (5)):1456-61.
15. Philipp C. Platelet disorders. In: Lee C, Kadir R, Kouides P, editors. Inherited bleeding disorders in women. Oxford, UK: Wiley-Blackwell; 2009. p. 65-9.
16. Byams VR, Kouides PA, Kulkarni R, Baker JR, Brown DL, Gill JC, et al. Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres. Haemophilia 2011;17(July (Suppl. 1)):6-13.
17. Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999;5(January (1)):40-8.
18. Kadir R. Gynaecology. In: Lee C, Kadir R, Kouides P, editors. Inherited Bleeding Disorders in Women. Oxford, UK: Wiley-Blackwell; 2009. p. 70-89.
19. Kouides PA, Phatak PD, Burkart P, Braggins C, Cox C, Bernstein Z, et al. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia 2000;6(November (6)):643-8.
20. Burger HG, Hale GE, Dennerstein L, Robertson DM. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 2000;15(November (4 Pt 1)):603-12.
21. Prior J. The ageing female reproductive axis II: ovulatory changes with perimenopause. Novartis Found Symp 2002;242:172-86, discussion 186-192.
22. Agarwal U, El Sheikh S, Kulkarni A, Baff D, Kadir RA. Von Willebrand factor expression in endometrial endothelial cells in women with menorrhagia. Fertil Steril 2010;94(November (6)):2335-7.
23. Kadir RA, Sabin CA, Pollard D, Lee CA, Economides DL. Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia 1998;4(November (6)):836-41.
24. Shankar M, Chi C, Kadir RA. Review of quality of life: menorrhagia in women with or without inherited bleeding disorders. Haemophilia 2008;14(January (1)):15-20.
25. Geukes M, van Aalst MP, Nauta MCE, Oosterhof H. The impact of menopausal symptoms on work ability. Menopause [Internet]. 2011 Oct 7 [cited 2012 Feb 4]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/21997498.
26. Cramer DW. Epidemiology of myomas. Semin Reprod Endocrinol 1992;10(4):320-4.
27. Kirtava A, Drews C, Lally C, Dilley A, Evatt B. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study. Haemophilia 2003;9(May (3)):292-7.
28. Lee CA, Chi C, Pavord SR, Bolton-Maggs PHB, Pollard D, Hinchcliffe-Wood A, et al. The obstetric and gynaecological management of women with inherited bleeding disorders-review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization. Haemophilia 2006;12(July (4)):301-36.
29. Silwer J. von Willebrand's disease in Sweden. Acta Paediatr Scand Suppl 1973;238:1-159.
30. O'Brien PM, DiMichele DM, Walterhouse DO. Management of an acute hemorrhagic ovarian cyst in a female patient with hemophilia A. J Pediatr Hematol Oncol 1996;18(May (2)):233-6.
31. Jarvis RR, Olsen ME. Type I von Willebrand's disease presenting as recurrent corpus hemorrhagicum. Obstet Gynecol 2002;99(May (5 Pt 2)):887-8.
32. Ghosh K, Mohanty D, Pathare AV, Jijina F. Recurrent haemoperitoneum in a female patient with type III von Willebrand's disease responded to administration of oral contraceptive. Haemophilia 1998;4(September (5)):767-8.
33. Vercellini P, De Giorgi O, Aimi G, Panazza S, Uglietti A, Crosignani PG. Menstrual characteristics in women with and without endometriosis. Obstet Gynecol 1997;90(August (2)):264-8.
34. D'Hooghe TM, Bambra CS, Raeymaekers BM, Koninckx PR. Increased prevalence and recurrence of retrograde menstruation in baboons with spontaneous endometriosis. Hum Reprod 1996;11(September (9)):2022-5.
35. MacLennan A, Lester S, Moore V. Oral oestrogen replacement therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2001;(1):CD002978.
36. Hickey M, Ambekar M. Abnormal bleeding in postmenopausal hormone users-What do we know today? Maturitas 2009;63(May (1)):45-50.
37. Callejon DR, Franceschini SA, Montes MBA, Toloi MRT. Hormone replacement therapy and hemostasis: effects in Brazilian postmenopausal women. Maturitas 2005;52(December (3-4)):249-55.
38. Post MS, van der Mooren MJ, van Baal WM, Blankenstein MA, Merkus HMWM, Kroeks MVAM, et al. Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study. Am J Obstet Gynecol 2003;189(November (5)):1221-7.
39. Guimarães DAM, das Graç as Carvalho M, Cardoso J, de Oliveira Sousa M, Franco RM, de Almeida Franco H, et al. Assessment of hypercoagulability markers and lipid levels in postmenopausal women undergoing either oral or transdermal hormone replacement therapy. J Thromb Thrombolysis 2009;27(February (2)):135-40.
40. Stevenson JC. HRT and cardiovascular disease. Best Pract Res Clin Obstet Gynaecol 2009;23(February (1)):109-20.
41. Gale A, Dey P. Postmenopausal bleeding. Menopause Int 2009;15(December (4)):160-4.
42. Lee CA, Chi C, Shiltagh N, Pollard D, Griffioen A, Dunn N, et al. Review of a multidisciplinary clinic for women with inherited bleeding disorders. Haemophilia 2009;15(January (1)):359-60.
43. Keeling D, Tait C, Makris M. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology. Haemophilia 2008;14(July (4)):671-84.
44. Edlund M, Blombäck M, Fried G. Desmopressin in the treatment of menorrhagia in women with no common coagulation factor deficiency but with prolonged bleeding time. Blood Coagul Fibrinolysis 2002;13(April (3)): 225-31.
45. Kadir RA. Menorrhagia: treatment options. Thromb Res 2009;123(Suppl. 2):S21-9.
46. Chi C, Huq FY, Kadir RA. Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up. Contraception 2011;83(March (3)):242-7.
47. Kingman CEC, Kadir RA, Lee CA, Economides DL. The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders. BJOG 2004;111(December (12)):1425-8.
48. James AH, Myers ER, Cook C, Pietrobon R. Complications of hysterectomy in women with von Willebrand disease. Haemophilia 2009;15(July (4)):926-31.
49. Castaman G, Rodeghiero F, Tosetto A, Cappelletti A, Baudo F, Eikenboom JCJ, et al. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2006;4(October (10)):2164-9.
50. Bolton-Maggs PHB, Perry DJ, Chalmers EA, Parapia LA, Wilde JT, Williams MD, et al. The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004;10(September (5)):593-628.
51. Huq FY, Al-Haderi M, Kadir RA. The outcome of endometrial ablation in women with inherited bleeding disorders. Haemophilia: Off J World Fed Hemophilia 2011;(December) [Epub. ahead of print].
52. Lee C, Berntorp E, Hoots W, Aledort L. Textbook of Hemophilia. Massachusetts: Blackwell Publishing Ltd.; 2005.
53. Kouides PA, Philipp C. Approach to the patient with an inherited bleeding disorder. In: Lee C, Kadir R, Kouides P, editors. Inherited bleeding disorders in women. Massachusetts: Blackwell Publishing Ltd.; 2009.